Lecap Asset Management Ltd. purchased a new position in shares of Avantor, Inc. (NYSE:AVTR – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 53,310 shares of the company’s stock, valued at approximately $1,217,000.
Several other institutional investors have also modified their holdings of AVTR. ORG Partners LLC purchased a new stake in Avantor in the 4th quarter valued at about $89,000. Cerity Partners LLC acquired a new position in shares of Avantor during the fourth quarter worth about $296,000. CKW Financial Group acquired a new position in shares of Avantor during the fourth quarter worth about $55,000. Olstein Capital Management L.P. grew its position in shares of Avantor by 2.9% during the fourth quarter. Olstein Capital Management L.P. now owns 315,000 shares of the company’s stock worth $7,191,000 after buying an additional 9,000 shares in the last quarter. Finally, Vaughan Nelson Investment Management L.P. grew its position in shares of Avantor by 8.4% during the fourth quarter. Vaughan Nelson Investment Management L.P. now owns 2,508,557 shares of the company’s stock worth $57,269,000 after buying an additional 194,031 shares in the last quarter. Hedge funds and other institutional investors own 95.08% of the company’s stock.
Avantor Price Performance
Avantor stock traded down $0.59 during trading hours on Friday, hitting $24.96. The stock had a trading volume of 2,534,053 shares, compared to its average volume of 3,900,933. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.61 and a quick ratio of 1.05. The stock has a market capitalization of $16.93 billion, a price-to-earnings ratio of 52.00, a PEG ratio of 1.61 and a beta of 1.37. Avantor, Inc. has a 1-year low of $16.63 and a 1-year high of $26.16. The stock’s fifty day moving average is $24.84 and its two-hundred day moving average is $22.34.
Avantor (NYSE:AVTR – Get Free Report) last posted its earnings results on Wednesday, February 14th. The company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.22 by $0.03. The company had revenue of $1.72 billion for the quarter, compared to analyst estimates of $1.70 billion. Avantor had a return on equity of 14.11% and a net margin of 4.61%. Avantor’s revenue was down 4.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.32 earnings per share. As a group, analysts predict that Avantor, Inc. will post 1.01 earnings per share for the current fiscal year.
Analyst Ratings Changes
AVTR has been the subject of a number of analyst reports. UBS Group boosted their price objective on Avantor from $25.00 to $29.00 and gave the stock a “buy” rating in a research report on Thursday, February 15th. JPMorgan Chase & Co. upped their price target on Avantor from $26.00 to $29.00 and gave the company an “overweight” rating in a report on Thursday, February 15th. Citigroup upped their price target on Avantor from $24.00 to $30.00 and gave the company a “buy” rating in a report on Thursday, February 15th. Royal Bank of Canada increased their price objective on Avantor from $28.00 to $29.00 and gave the company an “outperform” rating in a report on Thursday, February 15th. Finally, Barclays upped their price target on Avantor from $27.00 to $30.00 and gave the stock an “overweight” rating in a research note on Wednesday. Four research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $26.50.
Read Our Latest Analysis on Avantor
Insider Activity at Avantor
In related news, EVP James Bramwell sold 6,203 shares of the stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $24.49, for a total transaction of $151,911.47. Following the sale, the executive vice president now owns 101,143 shares of the company’s stock, valued at $2,476,992.07. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.50% of the company’s stock.
About Avantor
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Featured Articles
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Avantor, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Avantor wasn’t on the list.
While Avantor currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.